MWNA
FMTX

Marshall Wace North America’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Marshall Wace North America’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-184,875
Closed -$4.6M – 1822
2021
Q2 		$4.6M Hold
184,875
– – 0.02% 573
2021
Q1 		$5.18M Sell
184,875
-38,778
-17% -$1.4M 0.02% 548
2020
Q4 		$7.81M Buy
+223,653
New +$9.74M 0.04% 430

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Marshall Wace North America's FMTX Position: Q3 2021 in Review

Marshall Wace North America sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2021, closing a stake of 184,875 shares — an estimated $4.6M sold.

Marshall Wace North America first reported a position in FMTX in Q4 2020 and held it in 3 quarters. The position peaked at $7.81M in Q4 2020. 89 funds tracked by Wall St. Rank hold FMTX as of Q3 2021.

  • Marshall Wace North America reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 184,875 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2021, an estimated $4.6M.
  • Marshall Wace North America first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Marshall Wace North America's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $7.81M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.